RP

Robert Pullin

VI Vertex Pharmaceuticals Incorporated: 8 patents #233 of 896Top 30%
Merck: 3 patents #3,073 of 9,382Top 35%
Overall (All Time): #598,436 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12258333 N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels Elizabeth Mary Beck, Steven Durrant, Sarah Elizabeth Skerratt, Gorka Etxebarria Jardi, David Matthew Shaw +19 more 2025-03-25
12247021 Substituted tetrahydrofurans as modulators of sodium channels Steven Durrant, Nadia Ahmad, Elizabeth Mary Beck, Lidio Marx Carvalho Meireles, Ewa Iwona Chudyk +15 more 2025-03-11
12084438 GCN2 inhibitors and uses thereof Matthew Bleich, Jean-Damien Charrier, Huijun Dong, Steven Durrant, Meredith Suzanne Eno +11 more 2024-09-10
11919887 Substituted tetrahydrofurans as modulators of sodium channels Steven Durrant, Nadia Ahmad, Elizabeth Mary Beck, Lidio Marx Carvalho Meireles, Ewa Iwona Chudyk +15 more 2024-03-05
11834441 Substituted tetrahydrofurans as modulators of sodium channels Steven Durrant, Nadia Ahmad, Elizabeth Mary Beck, Lidio Marx Carvalho Meireles, Ewa Iwona Chudyk +15 more 2023-12-05
11827627 N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels Elizabeth Mary Beck, Steven Durrant, Sarah Elizabeth Skerratt, Gorka Etxebarria Jardi, David Matthew Shaw +19 more 2023-11-28
10988477 GCN2 inhibitors and uses thereof Andrew Bayly, Matthew Bleich, Jean-Damien Charrier, James Dodd, Steven Durrant +14 more 2021-04-27
10793563 GCN2 inhibitors and uses thereof Matthew Bleich, Jean-Damien Charrier, Huijun Dong, Steven Durrant, Meredith Suzanne Eno +11 more 2020-10-06